CN Patent

CN102872027B — 一种治疗肺部疾病的药物颗粒的制备和吸入式复方气雾剂的制备

Assigned to Medoncare Pharmaceutical Co ltd · Expires 2014-03-12 · 12y expired

What this patent protects

一种治疗哮喘类、肺部疾病的药物颗粒的制备和吸入式复方气雾剂的制备，本发明涉及由左旋硫酸沙丁胺醇或沙丁胺醇或沙丁胺醇生理上可接受的盐类的一种和布地奈德组成的药物颗粒和吸入式复方气雾剂制备。气雾剂中的药物组分是所述两种活性物质与环糊精、多糖类、聚乳酸、抗氧化剂中的一种或多种在超临界流体状态下形成的颗粒，颗粒平均直径在0.2μm与3μm之间，这种药物颗粒可以制成吸入式复方气雾剂。

USPTO Abstract

一种治疗哮喘类、肺部疾病的药物颗粒的制备和吸入式复方气雾剂的制备，本发明涉及由左旋硫酸沙丁胺醇或沙丁胺醇或沙丁胺醇生理上可接受的盐类的一种和布地奈德组成的药物颗粒和吸入式复方气雾剂制备。气雾剂中的药物组分是所述两种活性物质与环糊精、多糖类、聚乳酸、抗氧化剂中的一种或多种在超临界流体状态下形成的颗粒，颗粒平均直径在0.2μm与3μm之间，这种药物颗粒可以制成吸入式复方气雾剂。

Drugs covered by this patent

Patent Metadata

Patent number: CN102872027B
Jurisdiction: CN
Classification: —
Expires: 2014-03-12
Drug substance claim: No
Drug product claim: No
Assignee: Medoncare Pharmaceutical Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.